3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
6
Recruiting
4
Terminated
2
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
133
Lymphoid
44
Myeloid
31
Plasma cell
25
Classical hematology
12
Thoracic
8
Breast
6
Sarcoma
5
Dermatologic
5
Genitourinary
4
Gastrointestinal
4
CNS
3
Head & Neck
2
Gynecologic
2
Conditions
Ovarian Neoplasms
368
Uterine Cervical Neoplasms
144
Carcinoma, Ovarian Epithelial
108
Fallopian Tube Neoplasms
105
Endometrial Neoplasms
99
Breast Neoplasms
82
Carcinoma, Non-Small-Cell Lung
70
Neoplasms
55
Stomach Neoplasms
49
Melanoma
44
Colorectal Neoplasms
44
Neoplasm Metastasis
40
Pancreatic Neoplasms
37
Carcinoma, Renal Cell
36
Triple Negative Breast Neoplasms
33
Recurrence
31
Squamous Cell Carcinoma of Head and Neck
28
Lung Neoplasms
28
Uterine Neoplasms
25
Sarcoma
25
Urinary Bladder Neoplasms
24
Peritoneal Neoplasms
24
Uterine Cervical Dysplasia
23
Prostatic Neoplasms
23
Colonic Neoplasms
23
Esophageal Neoplasms
22
Head and Neck Neoplasms
21
Carcinoma, Transitional Cell
18
Testicular Neoplasms
16
Small Cell Lung Carcinoma
16
Interventions
sonidegib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Hematologic Neoplasms
×
Gynecologic
×
Clear all
NCT02900248
2019-04-02
N1
CureOne
Terminated
23 enrolled
NCT02002689
2016-05-02
SIGNATURE
Novartis
Phase 2
Terminated
10 enrolled
9 charts